WELLS FARGO & COMPANY/MN - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 47 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$123,000
-39.1%
196,954
-17.6%
0.00%
Q3 2019$202,000
+66.9%
239,006
+33.0%
0.00%
Q2 2019$121,000
-44.0%
179,716
-31.8%
0.00%
Q1 2019$216,000
-46.5%
263,355
+4.3%
0.00%
Q4 2018$404,000
-37.5%
252,415
+29.3%
0.00%
Q3 2018$646,000
+129.9%
195,143
+56.8%
0.00%
Q2 2018$281,000
-14.8%
124,465
+9.3%
0.00%
Q1 2018$330,000
+10.7%
113,892
+6.8%
0.00%
Q4 2017$298,000106,637
+13229.6%
0.00%
Q4 2016$0
-100.0%
8000.0%0.00%
Q3 2016$1,0000.0%8000.0%0.00%
Q2 2016$1,0000.0%8000.0%0.00%
Q1 2016$1,0000.0%8000.0%0.00%
Q4 2015$1,0000.0%8000.0%0.00%
Q3 2015$1,0000.0%8000.0%0.00%
Q2 2015$1,000
-50.0%
800
-50.0%
0.00%
Q1 2015$2,000
+100.0%
1,600
+100.0%
0.00%
Q4 2014$1,0000.0%8000.0%0.00%
Q3 2014$1,0000.0%8000.0%0.00%
Q2 2014$1,0000.0%8000.0%0.00%
Q1 2014$1,0000.0%8000.0%0.00%
Q4 2013$1,000
-50.0%
8000.0%0.00%
Q3 2013$2,0000.0%8000.0%0.00%
Q2 2013$2,0008000.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Greylock XI GP Limited Partnership 584,004$1,068,000100.00%
GREAT POINT PARTNERS LLC 2,325,000$4,255,0001.89%
Sarissa Capital Management LP 2,570,759$4,704,0001.60%
Deer VI & Co. LLC 675,242$1,236,0000.68%
Palo Alto Investors LP 1,200,800$2,197,0000.16%
Baupost Group 3,829,350$7,008,0000.11%
Gruss Capital Management LP 533,253$976,0000.05%
Granahan Investment Management 676,451$1,238,0000.04%
Fore Research & Management, LP 674,200$1,233,0000.04%
TFS CAPITAL LLC 210,369$385,0000.03%
View complete list of AVEO PHARMACEUTICALS INC shareholders